Coronary revascularization guided by iFR was noninferior to FFR for major adverse cardiac events, with fewer adverse signs and shorter procedural time using iFR.
Does iFR-guided coronary revascularization prevent major adverse cardiac events at 1 year as effectively as FFR-guided revascularization in patients undergoing PCI?
iFR-guided PCI is noninferior to FFR-guided PCI for 1-year major adverse cardiac events, while offering shorter procedural times and fewer adverse procedural symptoms.
Tasa de eventos absoluta: 0% vs 0%
Coronary revascularization guided by iFR was noninferior to revascularization guided by FFR with respect to the risk of major adverse cardiac events at 1 year. The rate of adverse procedural signs and symptoms was lower and the procedural time was shorter with iFR than with FFR. (Funded by Philips Volcano; DEFINE-FLAIR ClinicalTrials.gov number, NCT02053038 .).
Davies et al. (Sat,) reported a other. Coronary revascularization guided by iFR was noninferior to FFR for major adverse cardiac events, with fewer adverse signs and shorter procedural time using iFR.